Clinical Course of Lung Physiology in Patients with Scleroderma and Interstitial Lung Disease: Analysis of the Scleroderma Lung Study Placebo Group

BACKGROUND: Patients with scleroderma interstitial lung disease (SSc-ILD) are thought to have the greatest decline in lung function (forced vital capacity % predicted [FVC%]) in the early years after onset of systemic sclerosis (SSc). We assessed the natural history of FVC% decline in patients recei...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Khanna, Dinesh, Tseng, Chi-Hong, Farmani, Niloofar, Steen, Virginia, Furst, Daniel E., Clements, Philip J., Roth, Michael, Goldin, Jonathan, Elashoff, Robert, Seibold, James R., Saggar, Rajeev, Tashkin, Donald P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3183128/
https://ncbi.nlm.nih.gov/pubmed/21618205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.30467
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak